找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Erythropoietin; Wolfgang Jelkmann,Andreas J. Gross Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 anemia.blood.cells.c

[復(fù)制鏈接]
樓主: 調(diào)停
41#
發(fā)表于 2025-3-28 14:41:37 | 只看該作者
terleukin-3 (IL-3), the colony-stimulating factors (CSF) and erythropoietin (Epo) [8, 13, 62]. While the CSF induce the proliferation and differentiation of the pluripotent and committed progenitor cells [8], maturation of the late erythroid progenitors and erythroid precursors is mainly controlled by Epo [25].
42#
發(fā)表于 2025-3-28 21:48:36 | 只看該作者
Chemistry and Assays of Erythropoietin. Epo is the principal regulatory hormone of the circulating red cell mass [1,2] and is normally present in minute concentrations in serum at 15–30 milliunits/ml, or approximately 10. . [3–5]. The study of Epo has been hampered for many years by its extreme scarcity and the lack of a convenient assay.
43#
發(fā)表于 2025-3-28 23:15:16 | 只看該作者
44#
發(fā)表于 2025-3-29 06:10:51 | 只看該作者
45#
發(fā)表于 2025-3-29 07:17:57 | 只看該作者
46#
發(fā)表于 2025-3-29 14:54:15 | 只看該作者
Recombinant Human Erythropoietinttention must be paid to its quality in the sense of a functional replacement of the natural hormone. Accordingly, a detailed comparison of the human urinary extracted form with the recombinant product is given. For better understanding, the efforts at cloning and expression of the hormone in various cellular systems are discussed.
47#
發(fā)表于 2025-3-29 17:50:07 | 只看該作者
Recombinant Human Erythropoietin and ,-Retinoic Acid Therapy of Anemia in Hemodialysis and Peritonea the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in erythropoiesis [4–6].
48#
發(fā)表于 2025-3-29 20:51:12 | 只看該作者
49#
發(fā)表于 2025-3-30 02:50:41 | 只看該作者
50#
發(fā)表于 2025-3-30 07:07:47 | 只看該作者
Overview: 978-3-642-83747-0978-3-642-83745-6
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-21 22:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
怀安县| 东莞市| 云龙县| 张家口市| 遂宁市| 昌江| 梁河县| 宝清县| 罗甸县| 贺州市| 邵东县| 尖扎县| 集安市| 德化县| 渑池县| 平和县| 连州市| 安庆市| 信丰县| 长海县| 杭锦后旗| 张家界市| 万宁市| 民县| 万载县| 台中市| 中超| 屏东县| 遵义市| 建昌县| 昌吉市| 华宁县| 博野县| 富平县| 双桥区| 新巴尔虎右旗| 石屏县| 平乡县| 临清市| 壤塘县| 怀来县|